Dr. Jitendra Singh announced the soft launch of India’s first indigenous antibiotic, Nafithromycin, in November 2024. This antibiotic offers how many times more efficacy compared to azithromycin, with just three doses?

Correct option is C

The correct answer is (C) 10x

Explanation:

In November 2024, Dr. Jitendra Singh launched Nafithromycin, India’s first indigenous antibiotic developed for treating community-acquired respiratory infections. With just three doses, Nafithromycin was found to be 10 times more effective than azithromycin, a commonly used macrolide antibiotic. This represents a significant breakthrough in India’s pharma and health innovation landscape.

Information Booster:

• Developed under India’s National Biopharma Mission.

• Shows 10x greater efficacywith minimal dosing.

• Targets drug-resistant pathogens effectively.

• Manufactured indigenously, reducing import reliance.

• Enhances India’s stature in global antibiotic innovation.

• Backed by DBT-BIRAC and CSIR collaborations.

• Positioned as a new macrolide antibiotic with better resistance profile.